AI and Molecular Tools Advance Heart Disease Prediction and Treatment

TL;DR Summary
Scientists are developing a blood test measuring NT-Pro-BNP levels to predict the risk of complications in people with hypertrophic cardiomyopathy, potentially enabling targeted treatment and better management of the inherited heart condition.
Topics:top-news#biomarkers#blood-test#health#heart-condition#hypertrophic-cardiomyopathy#risk-prediction
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 3 min read
Condensed
95%
590 → 32 words
Want the full story? Read the original article
Read on The Guardian